Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou,China

Science China Life Sciences - Prolonged viral RNA shedding and recurrence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in coronavirus disease 2019 (COVID-19) patients have been...     

Transmission of synovial sarcoma from a single multi-organ donor to three transplant recipients: case report

Quick and reliable testing of EGFR and KRAS is needed in non-small cell lung cancer (NSCLC) to ensure optimal decision-making for targeted therapy. The Idylla™ platform was designed for Formalin-Fixed Paraffin-Embedded (FFPE) tissue sections but recently several studies were published that evaluated its potential for cytological specimens. This study aimed to validate the Idylla™ platform for the detection of EGFR/KRAS mutations in cytological NSCLC samples prepared as cytoblocks using AGAR and paraffin embedding. The KRAS Idylla™ test were performed on 11 specimens with a known KRAS mutation. The EGFR Idylla™ test was performed on 18 specimens with a known primary EGFR mutation and 7 specimens with a primary EGFR-EGFR T790M resistance mutation combination. Concordant KRAS and primary EGFR mutations were detected for both KRAS and primary EGFR mutations. Samples with a total CQ value of < 26 could be considered negative. Samples with a total CQ value of > 26 could not be assessed (probability of false-negative). In specimens with a primary EGFR-EGFR T790M resistance mutation combination, 5/7 cases were not concordant. Our results confirm the conclusion of recent reports that the Idylla™EGFR assay is not suitable in a resistance to EGFR TKI setting, also not in our cytological NSCLC samples prepared as cytoblocks using AGAR and paraffin embedding. KRAS and primary EGFR mutations were detected using the Idylla™ assays in virtually all cytological NSCLC samples. This analysis was rapid and time-saving compared to other mutation detection assays and may be useful if the amount of material is insufficient to perform a full set of molecular tests.     

LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging

LBX2-AS1 is a long non-coding RNA that facilitates the development of gastrointestinal cancers and lung cancer, but its participation in ovarian cancer development remained uninvestigated. Clinical data retrieved from TCGA ovarian cancer database and the clinography of 60 ovarian cancer patients who received anti-cancer treatment in our facility were analysed. The overall cell growth, colony formation, migration, invasion, apoptosis and tumour formation on nude mice of ovarian cancer cells were evaluated before and after lentiviral-based LBX2-AS1 knockdown. ENCORI platform was used to explore LBX2-AS1-interacting microRNAs and target genes of the candidate microRNAs. Luciferase reporter gene assay and RNA pulldown assay were used to verify the putative miRNA-RNA interactions. Ovarian cancer tissue specimens showed significant higher LBX2-AS1 expression levels that non-cancerous counterparts. High expression level of LBX2-AS1 was significantly associated with reduced overall survival of patients. LBX2-AS1 knockdown significantly down-regulated the cell growth, colony formation, migration, invasion and tumour formation capacity of ovarian cancer cells and increased their apoptosis in vitro. LBX2-AS1 interacts with and thus inhibits the function of miR-455-5p and miR-491-5p, both of which restrained the expression of E2F2 gene in ovarian cancer cells via mRNA targeting. Transfection of miRNA inhibitors of these two miRNAs or forced expression of E2F2 counteracted the effect of LBX2-AS1 knockdown on ovarian cancer cells. LBX2-AS1 was a novel cancer-promoting lncRNA in ovarian cancer. This lncRNA increased the cell growth, survival, migration, invasion and tumour formation of ovarian cancer cells by inhibiting miR-455-5p and miR-491-5p, thus liberating the expression of E2F2 cancer-promoting gene.     

ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments

The ADP-ribosylation factor-like proteins (ARLs) have been proved to regulate the malignant phenotypes of several cancers. However, the exact role of ARLs in gastric cancer (GC) remains elusive. In this study, we systematically investigate the expression status, interactive relations, potential pathways, genetic variations and clinical values of ARLs in GC. We find that ARLs are significantly dysregulated in GC and involved in various cancer-related pathways. Subsequently, machine learning models identify ARL4C as one of the two most significant clinical indicators among ARLs for GC. Furthermore, ARL4C silencing remarkably inhibits the growth and metastasis of GC cells both in vitro and in vivo. Moreover, enrichment analysis indicates that ARL4C is highly correlated with TGF-β1 signalling. Correspondingly, TGF-β1 treatment dramatically increases ARL4C expression and ARL4C knockdown inhibits the phosphorylation level of Smads, downstream factors of TGF-β1. Meanwhile, the coexpression of ARL4C and TGF-β1 worsens the prognosis of GC patients. Our work comprehensively demonstrates the crucial role of ARLs in the carcinogenesis of GC and the specific mechanisms underlying the GC-promoting effects of TGF-β1. More importantly, we uncover the great promise of ARL4C-targeted therapy in improving the efficacy of TGF-β1 inhibitors for GC patients.     

Synergistic inhibitory effect of berberine and icotinib on non-small cell lung cancer cells via inducing autophagic cell death and apoptosis

Apoptosis - Resistance to epidermal growth factor receptor-tyrosin kinase inhibitors (TKIs, e.g. icotinib) remains a major clinical challenge. Non-small cell lung cancer patients with wild-type...     

大连地区分泌型与非分泌型母亲母乳菌群结构的差异

目的探讨大连地区分泌型和非分泌型母亲哺乳期间母乳菌群的主要差异。方法于大连市妇幼保健院纳入42名志愿者产妇,收集其产后第6天的母乳样本。提取母乳样本DNA,并对包含rs601338和rs1047781单核酸位点多态性(SNP)的片段用聚合酶链式反应(polymerase chain reaction,PCR)检测并加以测序,以检测受试母亲岩藻糖基转移酶2基因(FUT2)的类型。采用16S rRNA高通量测序法对不同母乳样本中微生物的多样性进行分析,并且对不同母乳样本中的微生物丰度及类型展开探讨。结果母亲分泌型分布情况分析:42名志愿者中,36名母亲是分泌型,6名母亲是非分泌型。母乳菌群多样性分析:分泌型与非分泌型组母亲母乳菌群比较,发现反映组内差异的Alpha多样性指数(包括Ace、Chao1以及Shannon等)在2组间差异无统计学意义;通过使用主坐标分析,发现分泌型组和非分泌型组的距离相对较远,母乳菌群组内菌群结构类似,组间差异性较显著,说明母乳中的蛋白核心岩藻糖基化水平可明显改变母乳中菌群结构。乳汁菌群物种构成分析:从门水平分析,变形菌门与厚壁菌门为主要优势菌;从属水平分析,2组母乳菌群中的双歧杆菌属丰度差异较显著。相关性分析:分泌型母乳的菌群中相关基因的表达更强,说明分泌型母乳对菌群基因的表达有促进作用。结论母乳菌群构成在一定程度上受到母体FUT2基因类型,即母亲分泌型和非分泌型的影响。     

兰州兴隆山土壤微生物的分布及其相关特性分析

目的以兰州兴隆山不同区域的土壤微生物为研究对象,分析比较土壤微生物数量与土壤酶活性之间的相关性。方法利用不同方法测定土壤理化性质、微生物数量以及土壤相关酶活特性;采用三区划线法进行土壤微生物的分离与纯化,通过16S rDNA和ITS方法进行优势菌株鉴定。结果兰州兴隆山土壤中微生物菌群数量由多到少依次为细菌、放线菌、真菌。通过分离纯化后,对其中的2株优势菌进行了鉴定,初步推断X2为萎缩芽胞杆菌属(Bacillus atrophaeus)细菌,Z2为栎生青霉属(Penicillium glandicola)真菌。从酶活特性可知,阳面的土壤过氧化氢酶活性比阴面高;随着海拔高度的增加,过氧化氢酶活性呈现增加趋势;阳面的土壤脱氢酶活性总体比阴面高,并且随着海拔梯度的升高,土壤脱氢酶活性也在不断升高。从相关性分析可知,不同海拔土样间微生物数量与酶活性之间表现出明显的相关性。结论兰州兴隆山土壤微生物数量丰富,且细菌数量居多;不同阴、阳面土壤微生物的层次分布以及活性也各有不同。以上研究可为兰州兴隆山土壤生态系统演替等提供参考依据,并为土壤生态环境的治理做铺垫。     

阴道加德纳菌检出率及唾液酸酶A基因携带与细菌性阴道病的关系

目的探究阴道加德纳菌(Gardnerella vaginalis)检出率及唾液酸酶A基因携带与细菌性阴道病(BV)的关系。方法选择2017年1月至2019年8月确诊的BV患者82例作为BV组,并随机选择同时期健康女性82例作为健康组,比较2组人群G. vaginalis检出率和唾液酸酶A基因携带情况,相关统计学资料分析其对BV发生的影响。结果BV组人群G. vaginalis阳性检出率高于健康组(χ²=11.511,P<0.05)。BV组人群共检出G. vaginalis 1、2、3、4、5、6和7型,其中2型占比最高;BV组人群G. vaginalis 2、3、4型占比率高于健康组(χ²=4.148,17.009,9.973,均P<0.05)。BV组人群唾液酸酶A基因携带率高于健康组(χ²=39.234,P<0.05)。较健康组人群,BV组PCR DGGE宽度更窄,肠道菌群条带数少(t=9.217,P<0.05)。结论G. vaginalis检出率和唾液酸酶A基因携带情况与BV发生相关,有待成为相关生物学治疗靶点。